Literature DB >> 3026851

Agonist-induced alpha 1-adrenergic receptor changes. Evidence for receptor sequestration.

M Fratelli, A De Blasi.   

Abstract

Short-term receptor regulation by agonists is a well-known phenomenon for a number of receptors but little is known about the regulation of alpha 1-adrenergic receptors. In the present study we provide evidence of alpha 1-adrenergic receptor changes induced by agonists on DDT1 MF-2 smooth muscle cells. The cells were preincubated with the agonist and receptor changes were investigated in the cells washed free of the agonist. On cells pretreated with norepinephrine the number of receptors recognized by [3H]prazosin at 4 degrees C was reduced by 38%. The receptors were not degraded as the number of sites was the same in control and norepinephrine-treated cells when binding was measured at 37 degrees C. When binding was measured on fragmented membranes (at 4 degrees C), the number of receptors was the same in control and norepinephrine-treated cells, suggesting that the disruption of cellular integrity might expose receptors which are probably sequestered after agonist treatment. We conclude that agonists induced rapid sequestration of receptors on intact DDT cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3026851     DOI: 10.1016/0014-5793(87)81575-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Non classical, multiple-site interaction of [3H]-prazosin with the alpha 1-adrenoceptor of intact BC3H1 cells.

Authors:  F Sladeczek; C J Kirk; J Bockaert; B H Schmidt
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

2.  alpha(1B) adrenergic receptors in gonadotrophin-releasing hormone neurones: relation to Transport-P.

Authors:  S Al-Damluji; W B Shen; S White; E A Barnard
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  The oligosaccharide component of alpha 1-adrenergic receptors from BC3H1 and DDT1 muscle cells. Studies with glycosidases and photoaffinity labelling of intact cells.

Authors:  B I Terman; J F Reece; R D Brown; P A Insel
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

4.  Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade.

Authors:  V Steinkraus; M Nose; H Scholz; K Thormählen
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

5.  [High-dose intrathecal clonidine in the treatment of neuropathic tumor pain. Two case reports.].

Authors:  D Zech; R Sabatowski; L Badbruch; S Grond
Journal:  Schmerz       Date:  1995-11       Impact factor: 1.107

6.  Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial.

Authors:  Eugene McLaurin; Megan E Cavet; Paul J Gomes; Joseph B Ciolino
Journal:  Optom Vis Sci       Date:  2018-03       Impact factor: 1.973

7.  Low-dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials.

Authors:  Stacey L Ackerman; Gail L Torkildsen; Eugene McLaurin; Jason L Vittitow
Journal:  Clin Exp Optom       Date:  2018-12-07       Impact factor: 2.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.